Reduced NEDD4L expression, attributed to the upregulation of RAC2 expression, further promoted cell growth and migration, decreased cell apoptosis, and induced pro-tumorigenic immune and multiple tumor-associated pathways, resulting in ccRCC development. Here, RAC2 is linked to nonpapillary renal cell carcinoma.